AEON Biopharma Beheer
Beheer criteriumcontroles 2/4
AEON Biopharma's CEO is Marc Forth, appointed in Dec 2019, has a tenure of 4.92 years. total yearly compensation is $3.98M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 0.18% of the company’s shares, worth $61.56K. The average tenure of the management team and the board of directors is 3.3 years and 1.4 years respectively.
Belangrijke informatie
Marc Forth
Algemeen directeur
US$4.0m
Totale compensatie
| Percentage CEO-salaris | 13.8% |
| Dienstverband CEO | 4.9yrs |
| Eigendom CEO | 0.2% |
| Management gemiddelde ambtstermijn | 3.3yrs |
| Gemiddelde ambtstermijn bestuur | 1.4yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$306m |
| Mar 31 2024 | n/a | n/a | -US$137m |
| Dec 31 2023 | US$4m | US$550k | -US$385m |
| Sep 30 2023 | n/a | n/a | -US$45m |
| Jun 30 2023 | n/a | n/a | -US$78m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$5m | US$550k | -US$53m |
| Sep 30 2022 | n/a | n/a | -US$25m |
| Jun 30 2022 | n/a | n/a | -US$27m |
| Mar 31 2022 | n/a | n/a | -US$61m |
| Dec 31 2021 | n/a | n/a | -US$56m |
| Sep 30 2021 | n/a | n/a | -US$58m |
| Jun 30 2021 | n/a | n/a | -US$54m |
| Mar 31 2021 | n/a | n/a | -US$17m |
| Dec 31 2020 | US$3m | US$524k | -US$50m |
Compensatie versus markt: Marc's total compensation ($USD3.98M) is above average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Marc's compensation has been consistent with company performance over the past year.
CEO
Marc Forth (53 yo)
4.9yrs
Tenure
US$3,982,378
Compensatie
Mr. Marc Forth serves as Chief Executive Officer at AEON Biopharma, Inc., since December 2019 and also serves as its Principal Financial Officer since May 17, 2024 and serves as its President. Prior to AEO...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Principal Financial Officer | 4.9yrs | US$3.98m | 0.18% $ 61.6k | |
| Executive VP | 3.3yrs | US$1.40m | 0.052% $ 17.9k | |
| Chief Medical Officer | 3.4yrs | US$1.65m | 0.064% $ 22.1k | |
| Principal Accounting Officer | less than a year | geen gegevens | 0% $ 0 |
3.3yrs
Gemiddelde duur
46yo
Gemiddelde leeftijd
Ervaren management: AEON's management team is considered experienced (3.3 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Principal Financial Officer | 1.4yrs | US$3.98m | 0.18% $ 61.6k | |
| Independent Director | 1.4yrs | US$197.87k | 5.73% $ 2.0m | |
| Independent Director | 1.4yrs | US$198.86k | 0% $ 0 | |
| Chairman | 7.8yrs | US$862.46k | 0.11% $ 38.5k | |
| Independent Director | 1.4yrs | US$216.91k | 0% $ 0 | |
| Director | less than a year | geen gegevens | geen gegevens |
1.4yrs
Gemiddelde duur
70yo
Gemiddelde leeftijd
Ervaren bestuur: AEON's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.